Abstract
The study was designed to assess the cardiac release kinetics of the cytokines interleukin-1ß (IL-1ß), interleukin-6 (IL-6) and tumor-necrosis-factor-α (TNF-α) in patients with significant stenosis of the ramus interventricularis anterior. Ten patients were treated by bare metal stent implantation, 11 patients who underwent a diagnostic coronary angiography without intervention served as a control group. Cytokines paired blood samples were withdrawn from the coronary sinus and a peripheral vein immediately before and 1, 2, 6 h after the intervention. Myocardial ischemia was monitored by means of cardiac lactate metabolism and 12-lead electrocardiogram. After coronary intervention IL-6 gradually increased from a common baseline level of 1.34 ± 1.56 pg/ml to a maximum of 10.58 ± 5.7 pg/ml in the peripheral vein and 15.81 ± 6.98 pg/ml in the coronary sinus within 6 h with persistent higher levels in the coronary sinus indicating coronary IL-6 release. After 12 h the peripheral venous concentration of IL-6 returned to baseline levels. Neither in the study group for IL-1ß and TNF-α nor in the control group for any cytokine level significant changes were found. Myocardial ischemia was excluded in all patients. Uncomplicated percutaneous coronary intervention (PCI) was followed by a significant cardiac IL-6 release due to endothelial injury and not to myocardial ischemia.
Similar content being viewed by others
References
Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM (1992) Interleukin-1b in coronary arteries of patients with ischemic heart disease. Arterioscer Thromb Vasc Biol 16:1000–1006
Van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 90:36–44
Rifai N, Joubran R, Yu H, Asmi M, Jouma M (1999) Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 45:1967–1973
Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94:874–877
Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, Altamura S, Ciliberto G, Rebuzzi AG, Crea F, Pepys MB, Maseri A (1998) Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 98:2370–2376
Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A (1999) Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99:2079–2084
Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE (2000) Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis 9:217–222
Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772
Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Kobielusz-Gembala I (2003) Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis 14:431–438
Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, Pacheco R, Bursac Z, Grant A, Mehta JL (2007) Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 99:879–884
Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schömig A (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92:748–755
Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149–2153
Ikeda U, Ito T, Shimada K (2001) Interleukin-6 and acute coronary syndrome. Clin Cardiol 24:701–704
Brueckmann M, Bertsch T, Lang S, Sueselbeck T, Wolpert C, Kaden JJ, Jaramillo C, Huhle G, Borggrefe M, Haase KK (2004) Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin Chem Lab Med 42:1132–1139
Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K, Fujikawa H, Shimada K (2000) Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 84:9–10
Aggarwal A, Schneider DJ, Terrien EF, Gilbert KE, Dauerman HL (2003) Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response. J Thromb Thrombolysis 15:25–31
Kefer JM, Galanti LM, Hanet CE (2004) Time course of transcardiac interleukin-6 release after coronary stenting for stable angina. Heart 90:943–944
Kwaijtaal M, van Diest R, Bär FW, van der Ven AJ, Bruggeman CA, de Baets MH, Appels A (2005) Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary intervention. Atherosclerosis 182:341–348
Salgado Filho W, Martinez Filho EE, Horta P, Lemos PA, Migueletto BC, Serrano CV Jr, Ramires JA, Martinez TL (2005) Intracoronary inflammatory markers after percutaneous coronary interventions. Arq Bras Cardiol 85:180–185
Sardella G, Mariani P, D’Alessandro M, De Luca L, Pierro M, Mancone M, Porretta A, Accapezzato D, Fedele F, Paroli M (2006) Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res 117:659–664
Caixeta AM, Brito FS Jr, Costa MA, Serrano CV Jr, Petriz JL, Da Luz PL (2007) Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. Catheter Cardiovasc Interv 69:500–507
Jackson G, Atkinson L, Clark M (1978) Diagnosis of coronary artery disease by estimation of coronary sinus lactate. Br Heart J 40:979–983
Krüger D, Giannitsis E, Sheikhzadeh A, Stierle U (1998) Cardiac release and kinetics of endothelin after uncomplicated percutaneous transluminal coronary angioplasty. Am J Cardiol 81:1421–1426
Ramadan MM, Kodama M, Mitsuma W, Ito M, Kashimura T, Ikrar T, Hirono S, Okura Y, Aizawa Y (2006) Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease. Am J Cardiol 98:915–917
Gogo PB, Schneider DJ, Terrien EF, Watkins MW, Sobel BE, Dauerman HL (2005) Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention. Am J Cardiol 96:538–542
Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, Sütsch G, Roffi M, Neidhart M, Eberli FR, Tanner FC, Gobbi S, von Eckardstein A, Lüscher TF (2005) Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111:1355–1361
Goldberg A, Zinder O, Zdorovyak A, Diamond E, Gruberg L, Markiewicz W, Beyar R, Aronson D (2003) Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina. Am Heart J 146:819–823
Kilic T, Ural D, Ural E, Yumuk Z, Agacdiken A, Sahin T, Kahraman G, Kozdag G, Vural A, Komsuoglu B (2006) Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 92:1041–1046
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
ElMokhtari, N., Zschernitz, S., Sebens, S. et al. Cardiac release and kinetics of cytokines after elective bare metal coronary stenting. J Thromb Thrombolysis 30, 391–397 (2010). https://doi.org/10.1007/s11239-010-0466-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-010-0466-4